✦ LIBER ✦

5.1 Therapeutic Potential and Challenges of Targeting Receptor Tyrosine Kinase ROR1 with Monoclonal Antibodies in CLL

✍ Scribed by Jiahui Yang; Sivasubramanian Baskar; Ka Yin Kwong; Michael G. Kennedy; Adrian Wiestner; Christoph Rader

Book ID: 119218947
Publisher: Elsevier
Year: 2011
Tongue: English
Weight: 148 KB
Volume: 11
Category: Article
ISSN: 2152-2650
DOI: 10.1016/j.clml.2011.09.155

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of immunohistochemical analys

Comparison of immunohistochemical analysis with estrogen receptor SP1 and 1D5 monoclonal antibodies in breast cancer

✍ Madeira, Klesia Pirola; Daltoé, Renata Dalmaschio; Sirtoli, Gabriela Modenesi; R 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 675 KB

Phase 2 study of mapatumumab, a fully hu

Phase 2 study of mapatumumab, a fully human agonistic monoclonal antibody which targets and activates the TRAIL receptor-1, in patients with advanced non-small cell lung cancer

✍ Greco, F. Anthony; Bonomi, Philip; Crawford, Jeffrey; Kelly, Karen; Oh, Yun; Hal 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 214 KB

An Evaluation of the Drug Interaction Po

An Evaluation of the Drug Interaction Potential of Pazopanib, an Oral Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, Using a Modified Cooperstown 5+1 Cocktail in Patients With Advanced Solid Tumors

✍ Goh, B C; Reddy, N J; Dandamudi, U B; Laubscher, K H; Peckham, T; Hodge, J P; Su 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 291 KB

Phase II trial of mapatumumab, a fully h

Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer

✍ Trarbach, T; Moehler, M; Heinemann, V; Köhne, C-H; Przyborek, M; Schulz, C; Snel 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 318 KB

Two novel mutant alleles of the gene enc

Two novel mutant alleles of the gene encoding neurotrophic tyrosine kinase receptor type 1 (NTRK1) in a patient with congenital insensitivity to pain with anhidrosis: A splice junction mutation in intron 5 and cluster of four mutations in exon 15

✍ Marek Bodzioch; Katarzyna Lapicka; Charalampos Aslanidis; Marek Kacinski; Gerd S 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB 👁 3 views

Congenital insensitivity to pain with anhidrosis (CIPA), also called hereditary sensory and autonomic neuropathy type IV (HSAN IV), is caused by mutations of the NTRK1 gene coding for the neurotrophic tyrosine kinase receptor type 1. We report the results of the NTRK1 sequence analysis in a CIPA fam

Estimation of estrogen receptor content

Estimation of estrogen receptor content in fine-needle aspirates from breast cancer using the monoclonal antibody 1d5 and microwave oven processing: Correlation with paraffin embedded and frozen sections determinations

✍ Fernando Carlos Schmitt; Maria José Bento; Isabel Amendoeira 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 607 KB